Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells by Kuipers, H. et al.
Lipopolysaccharide-Induced Suppression of Airway Th2
Responses Does Not Require IL-12 Production by Dendritic
Cells1
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The prevalence of atopic asthma, a Th2-dependent disease, is reaching epidemic proportions partly due to improved hygiene in
industrialized countries. There is an inverse correlation between the level of environmental endotoxin exposure and the prevalence
of atopic sensitization. As dendritic cells (DC) have been implicated in causing sensitization to inhaled Ag, we studied the effect
of endotoxin on Th2 development induced by bone marrow DC in vitro and by intratracheal injection in vivo, with particular
emphasis on the role played by the polarizing cytokine IL-12. Bone marrow-derived DC stimulated with Escherichia coli O26:B6
LPS produced IL-12p70 for a limited period of time, after which production became refractory to further stimulation with CD40
ligand, a phenomenon previously called “exhaustion.” The level of IL-12 production of DC did not correlate with Th1 develop-
ment, as exhausted OVA-pulsed DC were still capable of shifting the cytokine pattern of responding OVA-specific Th cells toward
Th1 in vitro and in vivo. When mice were first immunized by intratracheal injection of OVA-DC and subsequently challenged with
OVA aerosol, prior in vitro stimulation of DC with LPS reduced the development of airway eosinophilia and Th2 cytokine
production. Most surprisingly, the capacity of LPS to reduce Th2-dependent eosinophilic airway inflammation was IL-12-inde-
pendent altogether, as IL-12p40 knockout DC had a similar reduced capacity to prime for Th2 responses. These results suggest
that LPS reduces sensitization to inhaled Ag by reducing DC-driven Th2 development, but that IL-12 is not necessary for this
effect. The Journal of Immunology, 2003, 171: 3645–3654.
T helper type 1 (Th1) and type 2 (Th2) effector cells playa pivotal role in the adaptive immune response towarddistinct classes of Ags (1). Dendritic cells (DC)3 are gen-
erally considered to be the principal APCs involved in the gener-
ation of polarized effector cells (2). However, the exact mecha-
nisms by which DC induce polarized Th responses are only
incompletely understood, and many of these mechanisms are com-
plementary. As such, the route of Ag encounter and the subtype of
DC presenting the Ag can profoundly influence Th differentiation
(3–6). The type of pathogen encountered or the adjuvant used for
DC activation has an even greater impact on Th cell differentiation.
DC-activating molecular patterns such as LPS (7), poly I:C (8),
and CpG motifs (9, 10) induce Th1 polarization by signaling
through pattern recognition receptors, while other products, like
soluble egg Ags of the helminth Schistosoma mansoni, glycopro-
teins from the filarial nematode Acanthocheilonema viteae, or
cholera toxin result in a skewing toward Th2 (8, 11). Recently, yet
another model of DC-induced Th cell polarization in vitro was
proposed (12). According to this “kinetics of activation” model, Th
cell differentiation following DC encounter with microbial com-
pounds is time-dependent, early in the response favoring Th1 ac-
tivation while later on favoring Th2 polarization.
All these different models of T cell polarization share the par-
adigmatic view that the type of Th response that arises correlates
closely with the capacity of DC to produce polarizing cytokines
such as bioactive IL-12, a dominant Th1-promoting cytokine (2, 4,
13, 14). Indeed, subsets of DC have differential capacity to pro-
duce IL-12 and many of the Th1-prone molecular patterns in mi-
crobes induce IL-12 production in DC (7–9, 13). Along the same
lines, the kinetics of activation model was explained by initial
strong production of IL-12 by LPS-stimulated DC, after which
prolonged stimulation would lead to exhaustion of IL-12 produc-
tion, thus favoring Th2 development (12). According to some
models, Th2 development indeed occurs as a default pathway
when DC fail to produce polarizing IL-12 (4), although the rele-
vance of this depends on the nature of the Ag and the experimental
model used (15–17).
The question of how and under which microbial control mech-
anisms DC induce stable Th polarization is particularly relevant to
atopic asthma. Atopic asthma is characterized by chronic eosino-
philic airway inflammation, and occurs in individuals with strongly
polarized Th2 recall responses to environmental allergen. The in-
cidence of atopy and asthma has greatly increased over recent
years, concomitant with an improved hygienic status in the indus-
trialized world, suggesting some form of environmental control
over Th2 development (18, 19). Interestingly, it has been reported
that exposure to high levels of LPS endotoxins during early child-
hood are correlated with a lower incidence of asthma later in life
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(20). The mechanisms by which this occurs are currently unknown
but systemic exposure to LPS during sensitization to inhaled Ag
decreased the severity of airway inflammation in animal models of
asthma (21, 22), possibly by shifting the balance of immune re-
sponsiveness toward Th1. We have previously shown in a murine
model of asthma, that airway DC are essential for inducing Th2
sensitization to inhaled allergen, leading to eosinophilic airway
inflammation (6, 23). As DC are also responsive to LPS, we set out
to study the effects of bacterial LPS on Th2 development induced
by DC in vitro and in the airways in vivo, with a particular emphasis
on the role played by the dynamic secretion of the polarizing cytokine
IL-12. Our data show that LPS reduces DC-driven Th2 development
in vitro and in vivo, through an IL-12-independent mechanism, re-
sulting in reduced eosinophilic airway inflammation.
Materials and Methods
Mice
Female BALB/c mice (6- to 10-wk-old) were purchased from Harlan
(Horst, The Netherlands). OVA323–339-specific, MHC class II-restricted,
TCR transgenic (DO11.10) (24), and IL-12p40/ mice crossed back on a
BALB/c background were obtained from The Jackson Laboratory (Bar
Harbor, ME). Mice were housed in microisolators under specified patho-
gen-free conditions and experiments were performed under approval of the
Erasmus University MC committee (Rotterdam, The Netherlands) for an-
imal ethics.
Antigen
Chromatographically purified OVA was obtained from Worthington Bio-
chemical (Lakewood, NJ). Endotoxin activity was 29 endotoxin units/mg,
which corresponds to 2.9 ng of LPS per milligram of OVA, as determined
by BioWhittaker Europe (Verviers, Belgium). This residual endotoxin ac-
tivity did not result in IL-12p70 production when added to bone marrow
(BM) DC cultures (data not shown). LPS (Escherichia coli, strain O26:B6)
was purchased from Sigma-Aldrich (St. Louis, MO).
Generation and stimulation of BM-derived DC
BM-derived DC were generated as described (25). After RBC lysis, BM
cells were resuspended at 2  105 per ml in DC culture medium (DC-CM;
RPMI 1640 containing glutamax-I (Invitrogen, Carlsbad, CA) supple-
mented with 5% (v/v) FCS (Biocell, Rancho Dominguez, CA), 50 M
2-ME (Sigma-Aldrich), 50 g/ml gentamicin (Invitrogen), and 20 ng/ml
recombinant mouse GM-CSF (a kind gift from Prof. K. Thielemans, Vrije
Universiteit Brussel, Brussels, Belgium). Cells (2  106) were seeded in
tissue-culture grade 100-mm Petri dishes (day 0). At day 3, 10 ml of fresh
DC-CM were added. On days 6 and 8, 10 ml of each plate were centrifuged
and resuspended in 10 ml of fresh DC-CM. At day 9, cells were pulsed for
24 h with either OVA (100 g/ml; OVA-DC), LPS (100–500 ng/ml; LPS-
DC), or a combination of these two (OVALPS-DC). In some experiments,
unstimulated DC (control-DC) were used as a negative control. At day 10,
mature DC were harvested by gentle pipetting. In some experiments, BM
cells were cultured in six-well plates, with cell numbers and culture vol-
umes adjusted to surface area. At day 9, LPS (25 ng/ml) was added for 8
or 24 h, cells were washed with DC-CM, and recultured for an additional
24 h either with or without soluble trimeric CD40L (sCD40L; a generous
gift of Dr. C. Maliszewski, Immunex, Seattle, WA) at 2.5 g/ml. After
24 h, cell recovery was determined and supernatants were kept at 20°C
until further analysis.
Real-time quantitative RT-PCR
Cells were harvested at various time points and total RNA was isolated
using the RNeasy kit (Qiagen, Hilden, Germany) according to manufac-
turer’s instructions. cDNA was generated from total RNA using random
hexamers and the Omniscript Reverse Transcriptase Kit (Qiagen). Relative
expression levels were determined with an ABI PRISM 7700 Sequence
Detector (Applied Biosystems, Foster City, CA). Primers and probes for
murine IL-12p40, IL-12p35, CCR7, and GAPDH were obtained from
PerkinElmer (Foster City, CA). PCR conditions were 50°C for 2 min, 95°C
for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min.
PCR amplification of the housekeeping gene GAPDH was performed to
control for sample loading and to allow normalization between samples.
Genomic DNA and water controls were included to ensure specificity. Data
are expressed as the ratio between cytokine/chemokine transcript levels
and GAPDH transcript levels.
CFSE labeling and analysis of T cell division
For fluorescent cell labeling, cells were washed twice with serum-free me-
dium, labeled with 1 M (DC) or 5 M (T cells) CFSE (Molecular Probes,
Oss, The Netherlands) in serum-free medium for 10 min at 37°C, and the
reaction was stopped by adding excess ice-cold DC-CM (26). For quanti-
fication of cell division based on serial halving of CFSE intensity, algo-
rithms provided by FlowJo software (Treestar, San Carlos, CA) were used.
The number of events n under each CFSE fluorescence peak i was deter-
mined using a nonlinear least-squares fitting of a series of Gaussian func-
tions. Once the data set had been fitted, the software derived two statistics
to describe the proliferation. The proliferation index (PRI) has been defined
as the average number of divisions of the cell fraction that divided (equa-
tion 1). The responder frequency (%D) has been defined as the percentage
of input cells that responded to stimulation by dividing (equation 2).
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In addition to cell division parameters, the original T cell pool that was
necessary to generate the total number of daughter cells can also be cal-
culated and compared between treatment groups (equation 3). Therefore,
this so-called “CFSE content” is an indicator of cell death and/or recruit-
ment of Ag-specific T cells within the lymph node.
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Th cell priming in vitro
Spleen and lymph node cells were isolated from DO11.10 mice and labeled
with CFSE. These cells (106/well) were cocultured in a 24-well plate with
OVA-DC (5  104/well), OVALPS-DC or control-DC. After 96 h, cells
were harvested and secretion levels of IL-4 and IFN- were detected by
flow cytometry.
DC migration and IL-12 staining in vivo
On day 0, mice (n  5) were anesthetized with avertin and 2  106 CFSE-
labeled OVA-DC or OVALPS-DC were injected intratracheally (i.t.) in a
volume of 80 l of PBS using the technique of Ho and Furst (27). After
36 h, the mediastinal lymph nodes (MLN) were isolated and pooled. As a
control for specific migration, the axillar lymph nodes (ALN) were re-
sected. Lymph nodes were incubated for 60 min at 37°C in digestion mix-
ture (collagenase type II, 1 mg/ml; Worthington Biochemical; DNaseI, 2
U/ml, Sigma-Aldrich), supplemented with monensin (Golgi-Stop; BD Bio-
sciences, Alphen a/d Rijn, The Netherlands). Frequency and IL-12p40 pro-
duction of CFSE DC were analyzed using flow cytometry.
Primary immune response following intratracheal injection of DC
On day 2, 107 CFSE-labeled DO11.10 TCR transgenic cells were adop-
tively transferred i.v. into naive BALB/c mice. On day 0, mice (n  9–10
per group) were i.t. immunized with 106 OVA-DC or OVALPS-DC. On
day 4, mice were sacrificed and MLN, ALN, and lungs were collected
separately. Single cell suspensions of lymph nodes were prepared by me-
chanical disruption and lungs were homogenized using digestion mixture.
Single cell suspensions were analyzed by flow cytometry or were restim-
ulated (2  106 cells per ml) with 10 g/ml OVA for 96 h, after which
supernatants were harvested and assayed for IL-4, IL-5, IL-10, IL-13, and
IFN- content.
Secondary immune response following i.t. injection of DC
On day 0, groups of mice (n  9–10 per group) were immunized i.t. with
1  106 OVA-DC or OVALPS-DC. In some experiments, control animals
received control-DC. From day 10 onward, mice were exposed to OVA
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aerosols (1% (w/v) in PBS) for 3–4 consecutive days, 30 min daily. Twen-
ty-four hours after the last exposure mice were sacrificed and bronchoal-
veolar lavage (BAL) was performed as described (6). MLN were isolated
and single cell suspensions were cultured in vitro as described above. As
a site-specific control, ALN of each group were pooled and treated iden-
tical to MLN.
Airway histology
After BAL, lungs were slowly inflated with 10% buffered formalin, the
right-middle lobe was excised, and fixed in formalin overnight. Subse-
quently, lungs were embedded in paraffin, 3-m sections were stained with
hematoxylin and periodic acid-Schiff (PAS) reagent (Sigma-Aldrich) and
photographed with a Leica DM-LB microscope (Rijswijk, The Nether-
lands).
Cytokine measurements
Levels of IL-12p70, IL-4, IL-5, IL-10, and IFN- in culture supernatants or
BAL were measured using OptEIA kits (BD Biosciences) according to
manufacturer’s instructions. IL-13 levels were measured using a commer-
cially available kit from R&D Systems (Minneapolis, MN)
Flow cytometry
To reduce nonspecific Ab binding, anti-FcRII Ab (2.4G2; American Type
Culture Collection, Manassas, VA) was included in all cell surface stain-
ings. To detect intracellular IL-12p40, single cell lymph node suspensions
were incubated for 3 h in the presence of monensin, followed by cell
surface staining. Subsequently, cells were fixed with 4% paraformaldehyde
for 20 min at 4°C. (Cells were either used directly or stored overnight in
FACSWash (PBS, 0.5% BSA, 0.05% NaN3)). Cells were then resuspended
in permeabilization buffer (Perm/Wash Buffer; BD Biosciences) and
stained for 30 min at 4°C. The following Abs were used: anti-CD3-PE
(145-2C11), anti-pan-NK-PE (DX5), anti-CD19-PE (1D3) in combination
with anti-IL-12p40-APC (C15.6) or an isotype-matched control.
To assess Th cell priming in vitro, IL-4 and IFN- secretion levels were
measured with cytokine secretion assays (Miltenyi Biotec, Bergisch Glad-
bach, Germany) according to manufacturer’s instructions. Briefly, cell cul-
tures were restimulated with plate-bound anti-CD3 (145-2C11; BD Bio-
sciences, 1 g/ml) and anti-CD28 (37.51, 4 g/ml) for 4 h and
subsequently labeled with the capture Ab for either IL-4 or IFN-. The
cells were then diluted in medium and allowed to secrete cytokines for 45
min at 37°C, under continuous rotation. CD4 T cells secreting cytokines
were identified by staining with PE-conjugated IL-4 or IFN- detection Ab
and CD4-allophycocyanin (RM4-5). Before acquisition, propidium iodide
(PI; 0.5 g/ml) was added for discrimination of dead cells.
To study the primary immune response in CFSE adoptive transfer ex-
periments, cells were labeled with anti-CD4-allophycocyanin in combina-
tion with the anti-clonotypic DO11.10 TCR Ab KJ1-26 (24), conjugated to
PE. Dead cells were excluded by labeling with PI before acquisition.
Anti-CCR3-PE was used to detect eosinophils in the lung (28), together
with anti-CD19-FITC (1D3), anti-CD8-PECy5 (53-6.7), and anti-
CD4-APC (RM4-5) to determine the cellular composition in BAL. All
fluorochrome-conjugated Abs were purchased from BD Biosciences, ex-
cept anti-CCR3-PE, which was from R&D Systems (Minneapolis, MN)
and anti-clonotypic-TCR-PE (KJ1-26), which was from Caltag Laborato-
ries (Burlingame, CA). Events (5  104–1.5  106) were acquired on a
FACSCalibur flow cytometer (BD Biosciences) and analyzed with FlowJo
software.
Statistical analysis
Reported values are expressed as mean  SEM, unless indicated other-
wise. Statistical analyses were performed with SPSS (Chicago, IL) using a
Mann-Whitney U test. Values of p  0.05 were considered significant.
Results
BM-derived DC express IL-12p70-encoding genes
IL-12p70 has been shown to be an important cytokine in the dif-
ferentiation and polarization of CD4 Th cells toward type 1 (29,
30). To investigate the IL-12p70 expression kinetics of murine
BM-derived DC in vitro, DC cultures were exposed to LPS (100
ng/ml) and relative mRNA expression levels of the subunit genes
IL-12p35 and IL-12p40 were determined. Both subunit genes were
up-regulated after LPS stimulation, reaching a maximum around
12 h after onset of stimulation (Fig. 1, A and B). After 24 h of
stimulation, expression levels of both subunit genes dropped sig-
nificantly and remained low thereafter. Although LPS-mediated
apoptosis of DC could be a possible explanation for the sharp
decrease in gene expression observed, the CCR7 mRNA levels
increased consistently after addition of LPS (Fig. 1C), arguing
against LPS-mediated cell death during culture.
The kinetics of IL-12 subunit gene expression suggested that no
IL-12p70 was produced beyond 24 h of LPS stimulation. To test
this hypothesis, cultured DC were stimulated for 8 or 24 h with
LPS, extensively washed and recultured either in medium (to as-
sess residual IL-12p70 production) or with sCD40L (to test IL-
12p70 production capacity after secondary stimulation). As shown
in Fig. 2, the residual release of IL-12p70 into fresh medium was
greatly reduced after LPS stimulation for 8 and 24 h (t). Of note
was the decreased production after 8 h of LPS stimulation, despite
the expression of the IL-12p35 and IL-12p40 genes (Fig. 1, A and
B), still maximal at this point. However, secretion of IL-12p70 was
restored by culturing the cells in a second stimulus provided by
sCD40L, a surrogate marker for T cell contact. This restoration did
not occur after prolonged LPS stimulation for 24 h (Fig. 2, ).
Levels of the DC maturation markers CD40, CD80, and CD86 also
increased after 24 h of LPS stimulation (data not shown). Alto-
gether, these data show that with progression in time, LPS-acti-
vated DC acquire a higher costimulatory phenotype, but exhaust
their IL-12 production capacity, in agreement with previous find-
ings with human monocyte-derived DC (12, 31).
FIGURE 1. Murine DC produce IL-12 transiently after LPS stimulation. BM-derived DC cultures were stimulated with LPS (100 ng/ml) at day 9. Cells
were harvested at indicated time points, total RNA was isolated and converted to cDNA. mRNA expression levels of IL-12p35 (A), IL-12p40 (B), and CCR7
(C) were determined by quantitative real-time RT-PCR. mRNA levels are displayed relative to GAPDH mRNA expression levels in each sample.
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Th cell activation with LPS-stimulated DC result in a reduced
Th2 profile in vitro
We next determined the functional consequences of LPS-induced
DC maturation and exhaustion of IL-12 secretion, on Th cell po-
larization in vitro. OVA-pulsed-DC (OVA-DC) were pretreated or
not for 24 h with LPS (OVALPS-DC) and were cocultured with
naive CFSE-labeled lymphocytes from OVA-TCR transgenic
mice. After 4 days, the cell division profile (Fig. 3A) as well as
IL-4 and IFN- secretion levels as a function of cell division num-
ber (Fig. 3B) of resulting Th effector cells were determined. LPS
stimulation had no significant effect on the stimulatory capacity of
DC, as the division profile of OVALPS-DC-stimulated Th cells
was almost similar to that of Th cells cultured with OVA-DC (Fig.
3A). This was confirmed by quantification of the cell proliferation,
which revealed no major changes in the average number of
divisions of the cell population that divided, hereafter referred
to as PRI (OVA-DC: 2.52  0.013, OVALPS-DC: 2.09 
0.023), and the responder frequency, defined as the cell popu-
lation that participated in clonal expansion (OVA-DC: 68.9 
0.58, OVALPS-DC: 75.3  2.12). In the OVA-DC group, se-
cretion of IL-4 increased with every cell division, reaching a
plateau after four divisions. The use of OVALPS-DC as APC
resulted in significantly decreased levels of IL-4 secretion in
each generation of dividing CD4 T cells compared with the
OVA-DC group (Fig. 3B). No major difference in IFN- secre-
tion was observed, with a large percentage of CD4 T cells
secreting IFN- irrespective of whether the DC were previously
stimulated with LPS or not (Fig. 3B). Consistent with these
single cell secretion data, IL-4 and IFN- levels in the super-
natant, as measured by ELISA, exhibited the same secretion
profile (data not shown). The levels of the Th2-associated cy-
tokines IL-5 and IL-13 were also decreased in the supernatant
of OVALPS-DC-stimulated T cell cultures (data not shown).
Thus, LPS stimulation of DC resulted in a selective decrease in
Th2 cytokine secretion in responding T cells, without affecting
Th1 cytokine secretion and despite the exhaustion of IL-12 pro-
duction in vitro. It is unlikely that this reduced Th2 develop-
ment was due to less stimulatory capacity or apoptosis of
OVALPS-DC, because IFN- production and T cell division
were similar compared with the OVA-DC group.
Effect of LPS stimulation of DC on proliferation and
differentiation of Ag-specific CD4 T cell response in vivo
Next, we examined the effect of LPS on the stimulatory and po-
larizing capacity of DC in vivo. CFSE-labeled, OVA-TCR trans-
genic T cells were adoptively transferred to syngeneic recipient
mice, which were subsequently immunized via the airways with
OVA-pulsed DC, either stimulated or not with LPS. After 4 days,
the frequency of OVA-specific T cells in the MLN, ALN, and
lungs was determined. In the MLN, up to seven generations of
divided cells could be distinguished (Fig. 4A). There was a slight
decrease in frequency of OVA-specific T cells in the OVALPS-DC
group compared with the OVA-DC group (0.48  0.06% vs
0.36  0.04%), respectively. Quantification of the cell prolifera-
tion revealed a small decrease in the PRI, as well as a decrease in
the responder frequency (Table I). The quantification of cell divi-
sion also enabled us to calculate the size of the original OVA-
specific T cell population the progeny had arisen from (CFSE con-
tent), revealing differences in cell number at any given site as a
FIGURE 2. IL-12p70-producing capacity upon restimulation depends
on duration of LPS stimulation. BM-derived DC were stimulated for 8 or
24 h with LPS (25 ng/ml). Supernatants were harvested (f) and cells were
washed with DC-CM. DC were cultured for an additional 24 h either in
DC-CM alone (t) or in the presence of sCD40L (2.5 g/ml; ). Super-
natants were harvested and the cell number of each condition was deter-
mined. IL-12p70 cytokine levels were measured by ELISA. The IL-12p70
levels are expressed on a per cell basis to account for differences in cell
numbers. The data are representative of duplicate experiments.
FIGURE 3. Stimulatory capacity of LPS stimulated DC on naive Th
cells and the type of effector Th cell generated. BM-derived DC were
pulsed with OVA protein (100 g/ml) in the absence or presence of LPS
(100 ng/ml). After a 24-h incubation, cells were thoroughly washed and
used to stimulate CFSE-labeled Th cells. Four days later, cells were har-
vested and IL-4/IFN- secretion was measured, together with the division
profile of CFSE-labeled cells. A, Division profile of living (PI), CD4
cells, stimulated with either OVA and LPS-pulsed DC (dashed line) or
OVA alone (solid line). B, IL-4 and IFN- secretion per generation of PI,
CD4 T cells stimulated with OVA-DC (Œ) or OVALPS-DC (f). Data is
depicted as percentage secretion above background. Background secretion
levels were defined as the cytokine secretion measured without stimulation
and were determined for each group and cytokine individually. Nonpulsed
or DC pulsed with LPS do not result in cell division or cytokine secretion
of Th cells (data not shown).
3648 IL-12-INDEPENDENT SUPPRESSION OF AIRWAY Th2 RESPONSES BY LPS
result of recruitment, migration, or cell death, independent of cell
division. There was no significant decrease in the original OVA-
specific T cell pool size in the OVALPS-DC group compared with
the OVA-DC group, indicating that LPS-stimulated DC were
equally capable to recruit naive T cells (Table I). Due to the in-
sufficient number of OVA-specific progeny T cells, we were un-
able to calculate the average division number of T cells in the
nondraining ALN. However, as evident from Fig. 4A, a minor
population of divided cells (more than three divisions) was present.
No significant differences in frequencies of the PI, KJ1-26 T
cell subset could be observed (OVA-DC: 0.47%  0.02%;
OVALPS-DC: 0.48%  0.02%). OVA-specific T cells that under-
went multiple divisions were also present in the lung but the num-
ber was insufficient to quantify the average cell division (Fig. 4A).
There were also no differences in the frequencies of the PI, KJ1-
26 T cell subset in the lung (0.117 0.015% vs 0.107 0.004%
for OVA-DC and OVALPS-DC, respectively).
To determine the consequences of LPS stimulation on Th cell
polarization in vivo, we also measured the cytokine levels of ex
vivo cultures of lymph node cells taken at day 4 of the primary
response after i.t. injection of DC (Fig. 4B). In the OVALPS-DC-
immunized animals, a decrease in the production of all Th2 cyto-
kines (IL-4, IL-5, IL-10, IL-13) with a concomitant increase in
IFN- secretion was observed when compared with OVA-DC, in-
dicating a clear shift in balance toward Th1 cytokine secretion.
Migration and IL-12 production of LPS-stimulated DC in vivo
Our in vitro experiments indicated that LPS stimulation of DC
resulted in exhaustion of IL-12p70 production after 24 h, which
would predict less Th1 development and more Th2 development in
responding T cells. However, our in vitro and in vivo polarization
experiments showed the opposite. To clarify this issue, we ana-
lyzed the expression of the IL-12p40 subunit by DC, previously
used as a marker for IL-12p70 production by DC in vivo (32), after
the migration of i.t. injected DC to the draining lymph nodes of the
lung. After incubation with OVA and/or LPS, DC were labeled
with CFSE and injected i.t. Thirty-six hours after instillation, there
was a substantial increase in the percentage (Fig. 5A) and number
(Fig. 5B) of OVALPS-DC migrating to the MLN compared with
OVA-DC. These findings of enhanced migration are consistent
with the up-regulation of CCR7 gene expression and down-regu-
lation of CCR5 and CCR6 expression following LPS stimulation
of BM-derived DC (Fig. 1C and data not shown). The same mi-
gration trend was observed when we looked at an earlier time point
(24 h; data not shown), which makes it unlikely that there is a
difference in migration kinetics between the two groups.
In contrast to the in vitro findings, OVALPS-DC produced more
IL-12p40 following migration to the draining MLN compared with
OVA-pulsed DC alone (Fig. 5C).
LPS stimulation of DC results in decreased development of
eosinophilic airway inflammation
Despite the discrepancies between T cell polarization capacity and
IL-12 secretion capacity of LPS-stimulated DC, the above data
demonstrate that LPS-stimulated DC reduce Th2 development dur-
ing the primary immune response. We next examined the effect of
LPS activation of DC in a relevant Th2 dependent mouse model of
FIGURE 4. LPS-stimulated DC have equal stimulatory capacity but a
distinct Th cell differentiation capacity. Naive BALB/c mice received a
cohort DO11.10 T cells (KJ1-26) and were subsequently immunized with
either OVA-pulsed DC (n  9) or OVA  LPS-pulsed DC (n  10). Four
days later, MLN, ALN, and lungs were resected and analyzed for CFSE
T cells directly or cultured in vitro in the presence of OVA for 4 days. A,
Frequency and cell division profile of OVA transgenic T cells in the MLN,
ALN (PI, CD4), and lungs (PI) was assessed by flow cytometry. Dot
plots shown are from representative mice of each group. B, Cytokine levels
after in vitro restimulation with OVA. No cytokines could be detected in
cultures of ALN (data not shown). Results are expressed as mean  SEM
from five mice per group. , p  0.05
Table I. Quantification of OVA-specific CD4 T cell proliferation in
the MLN
Immunization PRIa
Responder
Frequencyb
CFSE Content/
105 PI Cellsc
OVA-DC 1.97 0.04d 15.70  0.67 237  35
OVALPS-DC 1.82 0.04 11.98  1.30 211  17
a Defined as the average number of divisions of the CD4, KJ1-26, PI cell
population that divided.
b Defined as the percentage of input CD4, KJ1-26, PI cells that responded to
stimulation by dividing.
c Defined as the original T cell pool size necessary to generate the total number of
daughter cells present, expressed per 105 living cells.
d Values represent the mean  SEM of the data (n  4–5 animals per group).
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eosinophilic airway inflammation (6). In this model, sensitization
to OVA is induced by i.t. injection of OVA-DC, followed by OVA
aerosol challenge 10 days later, resulting in peribronchial and
perivascular eosinophilic airway inflammation. When mice were
immunized with control DC and subsequently challenged with
OVA aerosol, there was no airway inflammation (data not shown
and Ref. 6). When analyzing the degree of lung inflammation,
immunization with OVALPS-DC revealed only a slight decrease
in total cell number in BAL fluid compared with OVA-DC (Fig.
6A). However, the cellular composition of the BAL fluid was
markedly different. A significant decrease in the frequency of eo-
sinophils was observed, accompanied by an increase in frequency
of alveolar macrophages in the mice immunized with
OVALPS-DC (Fig. 6A). The frequency of T cells in BAL fluid was
identical in both groups. Lung histology data were in concordance
with BAL data, with lower but marked cellular infiltrate and mucus
secretion in the OVALPS-DC group compared with the OVA-DC
group (Fig. 6D). To explain why the development of airway eo-
sinophilia was suppressed despite similar T cell recruitment, we
also measured cytokine levels in lungs and MLN. In the BAL fluid
there was a decrease in the levels of IL-5 and IL-13 after immu-
nization with OVALPS-DC compared with OVA-DC (Fig. 6B).
Th2-associated cytokine levels were also decreased in the MLN, in
particular IL-4, IL-5, IL-10, and IL-13, while the levels of the Th1
cytokine IFN- did not significantly change following LPS stim-
ulation of OVA-DC (Fig. 6C). These results suggest that LPS-
stimulated DC, while still eliciting an immune response, have re-
duced capacity to prime for Th2 effector cells.
LPS-mediated suppression of Th2 development in vivo does not
require IL-12
In an attempt to dissect the contribution of DC-derived IL-12 and
recipient-derived IL-12 on Th2 effector cell generation in vivo, we
first immunized wild-type mice with DC derived from IL-12p40
homozygous knockout mice. In the absence of LPS stimulation,
BAL fluid analysis revealed that IL-12p40/ OVA-DC induced a
stronger Th2 response compared with wild-type OVA-DC, as the
levels of BAL fluid eosinophilia were higher (Fig. 6A) and Th2
cytokine levels in BAL fluid revealed a significant increase in the
Th2 cytokines IL-5 and IL-13 in the IL-12p40/ group (Fig. 6B).
Restimulation of lymph node cells in vitro also showed an increase
for the Th2 cytokines in the IL-12p40/ group (Fig. 6C). To our
surprise, LPS stimulation of IL-12p40/ OVA-DC had a similar
suppressive effect compared with LPS stimulation of wild-type
OVA-DC. In the IL-12p40/ OVALPS-DC group, there was a
slight decrease in total cell number accompanied by a statistical
significant change in cellular composition, consisting of a decrease
in the frequency of eosinophils and an increase in the frequency of
alveolar macrophages compared with the IL-12p40/ OVA-DC
group (Fig. 6A). Additionally, the levels of IL-5 and IL-13 were
significantly lower in BAL fluid of IL-12p40/ OVALPS-DC
mice compared with the IL-12p40/ OVA-DC group (Fig. 6B).
Finally, Ag-specific restimulation of MLN cells in vitro revealed
lower levels of the Th2-specific cytokines measured, in particular
IL-5 and IL-10, accompanied by a significant increase in the levels
of IFN- after stimulation with LPS (Fig. 6C). To rule out any role
for IL-12 in Th2 differentiation in this model, we next immunized
IL-12p40/ mice with IL-12p40/-derived DC. Immunization
with OVALPS-DC resulted in lower total cell number, frequency
of eosinophils, and Th2-associated cytokines in the BAL compart-
ment, compared with OVA-DC-immunized mice (Fig. 7). In sum-
mary, these data suggest that suppression of Th2 effector cell de-
velopment by LPS stimulation of DC occurs independently of
IL-12 secretion by either adoptively transferred DC or recipient-
derived IL-12.
Discussion
Th cell polarization is influenced by the route of Ag exposure, the
subtype of DC presenting the Ag, the dose of Ag, the genetic
background of the host, and most importantly, by the nature of the
Ag (2). It is increasingly clear that different molecular patterns
FIGURE 5. LPS increases migration and IL-12 production of DC in
vivo. OVA-pulsed DC (OVA-DC) and OVA  LPS-pulsed DC
(OVALPS-DC; both 2  106/mice) were CFSE-labeled and injected i.t.
(n  5 per group). Thirty-six hours later, MLNs from each group were
isolated, pooled, and analyzed by flow cytometry for migration and IL-12
production of injected DC. As a control for specific migration, the ALNs
of the OVALPS-DC were analyzed as well. Frequency (A) and total num-
ber (B) of CFSE DC. C, IL-12p40 staining of CFSE DC. Solid histo-
gram, isotype-matched control; regular line, OVA-DC group; bold line,
OVALPS-DC group. Cells (1.5  106) per sample were acquired. Data are
representative of three independent experiments.
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expressed on pathogens can fundamentally influence Th differen-
tiation by signaling through molecular pattern recognition recep-
tors on DC (33, 34). The way by which these various factors are
integrated by DC into a signal that can determine Th cell polar-
ization is an area of intense research but involves the generation of
a particular peptide-MHC density (signal 1), the provision of a
particular combination of costimulatory molecules (signal 2), and
the secretion of polarizing cytokines such as IL-12, IL-18, and
IL-27 (2, 8, 35, 36). Many of the microbial patterns such as bac-
terial LPS, peptidoglycan, CpG motifs, and viral dsRNA, induce
the secretion of IL-12 by signaling through the Toll-like receptors
and the myeloid differentiation factor 88 signaling pathway, thus
inducing polarization toward Th1 responses (16, 34).
We have examined the role of DC-derived IL-12 in LPS-medi-
ated suppression of Th2 responses and took into account the re-
cently proposed mechanism by which DC exert their influence on
Th cell polarization by dynamic and time-dependent secretion of
IL-12p70 (12, 31). We have shown that in vitro BM-derived DC
stimulated with LPS express IL-12p35 and IL-12p40 mRNA only
transiently, in line with other reports (37), while the expression of
other maturation markers such as the chemokine receptor CCR7
gradually increased over time. Of note, the IL-12p40 and IL-12p35
peaked at around 12 h post-LPS activation, followed by a steep
decline in relative expression. The capacity to produce IL-12p70
upon restimulation with a surrogate T cell contact provided by
sCD40L also decreased with increasing duration of the LPS
FIGURE 6. LPS-activated DC reduce inflammation in a mouse model of eosinophilic airway inflammation independent of DC-derived IL-12. On day
0, groups of mice were immunized by i.t. administration of 1  106 OVA-DC or OVALPS-DC, derived from either wild-type or IL-12p40/ mice. On
days 10–13, mice were exposed to OVA aerosols for 30 min daily. At 24 h after the last exposure mice were sacrificed, BAL was performed and lymph
nodes were isolated as described in Materials and Methods. A, Cellular composition of BAL fluid. Alveolar macrophages were characterized by their light
scatter and autofluorescence properties. Eosinophils are defined by their CCR3, CD4, CD8 staining pattern. The T cell fraction consists of CD4 and
CD8 cells within the appropriate light scatter gate. B, Cytokine levels in BAL fluid. C, Cytokine levels after in vitro restimulation of MLN cells with OVA
Ag. Note that ALN cells of each group were pooled and cultured in an identical manner. No cytokines could be detected in these cultures (data not shown).
Results are expressed as means  SEM from 8–10 mice per group. , p  0.05. Data are representative for one to three independent experiments. D,
Leukocyte infiltration and PAS staining in lungs of wild-type OVA-DC or OVALPS-DC-immunized mice. Solid arrowheads indicate cellular infiltrate,
open arrowheads indicate mucus accumulation (PAS)
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stimulus, a phenomenon previously termed “IL-12 exhaustion.”
Surprisingly, despite exhaustion of IL-12 production, LPS-stimu-
lated DC used as APC resulted in a more pronounced Th1 pheno-
type of Th cells in vitro, where individual T cells produced dra-
matically decreased levels of IL-4 and maintained levels of IFN-.
Therefore, on a population level, the Th cell differentiation was
skewed toward Th1, a finding also supported by the ELISA data.
This was not due to a decreased strength of stimulation due to
apoptosis of DC, as the overall degree of naive T cell activation
was similar in both groups. Our findings are in contrast with a
study of Langenkamp et al. (12), which concluded that LPS-in-
duced IL-12 exhaustion in human monocyte-derived DC contrib-
uted to enhanced Th2 and nonpolarized central memory Th0 de-
velopment. In this in vitro model, human naive T cells were
stimulated by the TSST-1 superantigen on syngeneic human
monocyte-derived DC, and reacting T cells were expanded for 3–9
days in neutral conditions using IL-2 before analysis of intracel-
lular cytokine content, which might explain differences in out-
come. To clarify this discrepancy further, we also examined the
relevance of our findings in vivo, where DC interact with naive
Ag-specific T cells in the T cell area, providing a physiologically
relevant stimulus for terminal functional maturation of DC func-
tion, rather than the artificial CD40L stimulation in vitro (38, 39).
To our surprise, we saw that DC that were pulsed with LPS for
24 h and subsequently injected into the lungs migrated to the drain-
ing lymph nodes and were still producing IL-12p40 36 h after
injection. It is possible that in vivo, many other ligand/receptor
interactions in addition to CD40/CD40L contribute to the rescue of
IL-12 synthesis. As such, other members of the TNF/TNFR family
have been shown to enhance the terminal differentiation of DC as
they reach the T cell area (40). Not surprisingly, in vivo, the LPS-
stimulated DC also induced the proliferation and differentiation of
naive OVA-specific T cells toward Th1 cells producing mainly
IFN-, whereas unstimulated DC induced T cells that made pre-
dominantly IL-4, IL-5, IL-10, and IL-13. Therefore, the in vivo
data about Th polarization support the in vitro data and argue
against the theory that IL-12 exhaustion would contribute to en-
hanced Th2 development (12). Based on the observed inconsis-
tency between IL-12 production capacity and Th cell polarization
by DC, we next studied the relevance of LPS-induced IL-12 pro-
duction by DC using an established model of Th2 effector cell-
driven eosinophilic airway inflammation that uses DC for immu-
nization (6, 41). As DC can be manipulated in vitro before
injection in vivo, this model is very useful to address the direct
effects of LPS on sensitization via the airways, without avoiding
the effects of LPS on other cells in the lungs. When DC were
pretreated with LPS before injection into the trachea, in particular
the allergen-induced influx of eosinophils was markedly de-
creased. Cytokines associated with eosinophilic airway inflamma-
tion, IL-5 and IL-13, were also decreased in the lung. Histological
findings were in agreement with the BAL data, with decreased, but
not totally absent, cellular infiltrates and mucus secretion. This
reduced inflammation in the lung was accompanied by a shift in
the cytokine profile in the draining MLN toward a Th1 type of
response, with decreased levels of Th2-associated cytokines.
It has been shown that IL-12 has the capacity to down-regulate
eosinophilic airway inflammation and airway hyperreactivity in
mouse models of asthma, when given during the sensitization
phase of the response (42–44). It has been hypothesized that IL-12
exerts its effect via induction of a Th1 type of response that re-
ciprocally dampens the Th2 responses involved in asthma, analo-
gous to what has been shown in models of parasitic infection (45).
Moreover, immunization with DC that constitutively express high
levels of IL-12 dramatically reduces eosinophilic airway inflam-
mation (H. Kuipers, D. Hijdra, and B. N. Lambrecht, unpublished
data). As LPS induced an increase in IL-12 production in DC
following adoptive transfer in vivo we initially hypothesized that
the development of eosinophilic airway inflammation was sup-
pressed through the release of IL-12 in vivo. However, to our
surprise, the experiments with IL-12p40 knockout mice indicated
that the LPS-induced suppression of eosinophilic inflammation
was independent of DC-derived IL-12. Moreover, when both the
immunizing DC and the recipient mice could not produce IL-12,
LPS was still capable to suppress airway inflammation. A possible
explanation for this IL-12 independent effect of LPS might be that
alternative pathways or cytokines were involved. Freudenberg et
al. showed IL-12-independent IFN- production by Gram-negative
bacteria via STAT4 activation with type I IFN and IL-18 (46).
Other papers that reviewed the role of IL-12 in Th cell differen-
tiation also found that Th1 cells did develop in the absence of
IL-12 (16, 47). In both cases, however, IL-12 did amplify the Th1-
dependent immune response. The recently described cytokine
IL-27 may also be important as it induces IFN- production by
naive T cells and is produced by APC. Importantly, its expression
is up-regulated upon activation by LPS and mice deficient for its
receptor TCCR have impaired Th1 responses (36, 48). Another
novel candidate cytokine expressed by DC is IL-23, which shares
the p40 subunit with IL-12 (49). Because the IL-12-deficient mice
carry an inactivated p40 subunit, the Th1 polarizing capacity of the
DC in these experiments cannot be attributed to this cytokine. One
finding that also appeared from our studies using IL-12p40 knock-
out mice was the enhanced Th2 response that was induced in the
absence of IL-12 production by DC. It is less-established how DC
can polarize Th2 responses as there is very little if any evidence
that they can produce the Th2 skewing cytokine IL-4 (2). Perhaps
the simplest model for Th2 polarization would be one in which Th
cells default to the Th2 pathway in the absence of IL-12 secretion
by DC. Cholera toxin, IL-10, and PGE2 indeed induce Th2 devel-
opment by suppressing the production of IL-12 in DC in vitro (4,
50). However, in the absence of IL-12, CD4 T cell responses to
FIGURE 7. LPS-activated DC reduce airway inflammation indepen-
dently of IL-12. A similar experiment as described in Fig. 6 was performed
with IL-12p40/ mice-derived DC transferred into IL-12p40/ recipi-
ents. A, Cellular composition of BAL fluid. B, Cytokine levels in BAL
fluid. Results are expressed as means  SEM from eight mice per group.
, p  0.05
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the intracellular pathogens Toxoplasma gondii and Mycobacterium
avium and to the parasite Trichinella spiralis fail to default to the
Th2 pathway in vivo (16, 17). Therefore, the exact contribution of
DC-derived IL-12 to Th cell polarization is unclear and depends on
the nature of the Ag and the experimental model used (4, 8, 16,
17). However, it has been suggested that deficient production of
IL-12 by APC of allergic donors might be a key determinant of
allergic sensitization (51, 52). In accordance with this, it was re-
cently shown that polymorphisms in the IL-12p40 promoter gene,
leading to lower levels of produced IL-12, are clearly associated
with the development of atopic sensitization (53), a finding here
supported by our data in the mouse model.
The findings in our study that LPS stimulation of DC during the
priming alters the outcome of Th responses has implications for
understanding the development of atopic sensitization. Studies of
the effect of LPS on asthma appear to be complex. Epidemiolog-
ical data has established a correlation between high endotoxin lev-
els on farms and reduced likelihood of children living on these
farms to develop asthma (20), while other studies found that en-
dotoxins augment the severity of asthma once it is established (54,
55). The effect of LPS in animal models of asthma has also been
conflicting, with most studies assigning a protective role to LPS
(21, 22, 56), while others do not (57), probably depending on the
time and route of Ag and/or LPS administration. One study im-
plicated that the outcome of sensitization is dependent on the dose
of LPS present during priming, with high doses favoring a Th1
response and low doses a Th2 response (58). However, the ma-
jority of studies that administer LPS before or during sensitization
show a decrease in airway inflammation, although it is not exactly
clear if this is due to an increase in Th1 effector function. Other
bacterial factors that suppress development of Th2-associated sen-
sitization and eosinophilic airway inflammation such as bacterial
CpG motifs have also been shown to exert their effects indepen-
dently of IL-12 and even IFN-, suggesting that they do not work
by inducing a counterregulatory Th1 population (59). A recent
epidemiological study in German children correlated current levels
of LPS exposure in mattress covers with risk of atopic sensitization
and diseases and found that increasing levels of LPS exposure led
to reduced occurrence of atopic diseases, but also to lower levels
of IL-12 production in polyclonally stimulated PBMCs, again ar-
guing against a dominant role for IL-12 production in mediating
the effects of LPS on sensitization (60). We are currently address-
ing whether LPS-stimulated DC reduce eosinophilic airway in-
flammation by inducing a particular population of regulatory T
cells, which have been shown to be involved in tolerance induction
in the lung (61). Indeed, other bacterial motifs such as those
present in Mycobacterium vaccae suppress eosinophilia by such a
mechanism (62).
To summarize, we have shown that LPS stimulation of DC sup-
presses the Th2-dependent development of eosinophilic airway in-
flammation independently of IL-12. In addition, the IL-12 expres-
sion levels of DC could not predict their polarizing capacity in
vitro and in vivo, arguing against the recently proposed pathway of
kinetics of activation, in which LPS-induced exhaustion of IL-12
secretion determines Th cell polarization.
Acknowledgments
We are grateful to K. Thielemans for providing recombinant mouse GM-
CSF and C. Maliszewski for providing sCD40L. We also thank S. Manning
for expert technical assistance with quantitative RT-PCR, and Nanda Vos
and Monique Willart for histology work.
References
1. Abbas, A. K., and C. A. Janeway, Jr. 2000. Immunology: improving on nature in
the twenty-first century. Cell 100:129.
2. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2
development. Nat. Immunol. 1:199.
3. Maldonado-Lopez, R., T. De Smedt, P. Michel, J. Godfroid, B. Pajak,
C. Heirman, K. Thielemans, O. Leo, J. Urbain, and M. Moser. 1999. CD8 and
CD8 subclasses of dendritic cells direct the development of distinct T helper
cells in vivo. J. Exp. Med. 189:587.
4. Maldonado-Lopez, R., C. Maliszewski, J. Urbain, and M. Moser. 2001. Cyto-
kines regulate the capacity of CD8 and CD8 dendritic cells to prime Th1/
Th2 cells in vivo. J. Immunol. 167:4345.
5. Stumbles, P. A., J. A. Thomas, C. L. Pimm, P. T. Lee, T. J. Venaille, S. Proksch,
and P. G. Holt. 1998. Resting respiratory tract dendritic cells preferentially stim-
ulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals
for induction of Th1 immunity. J. Exp. Med. 188:2019.
6. Lambrecht, B. N., M. De Veerman, A. J. Coyle, J. C. Gutierrez-Ramos,
K. Thielemans, and R. A. Pauwels. 2000. Myeloid dendritic cells induce Th2
responses to inhaled antigen, leading to eosinophilic airway inflammation.
J. Clin. Invest. 106:551.
7. Pulendran, B., P. Kumar, C. W. Cutler, M. Mohamadzadeh, T. Van Dyke, and
J. Banchereau. 2001. Lipopolysaccharides from distinct pathogens induce differ-
ent classes of immune responses in vivo. J. Immunol. 167:5067.
8. de Jong, E. C., P. L. Vieira, P. Kalinski, J. H. Schuitemaker, Y. Tanaka,
E. A. Wierenga, M. Yazdanbakhsh, and M. L. Kapsenberg. 2002. Microbial
compounds selectively induce Th1 cell-promoting or Th2 cell-promoting den-
dritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 168:1704.
9. Sparwasser, T., E. S. Koch, R. M. Vabulas, K. Heeg, G. B. Lipford, J. W. Ellwart,
and H. Wagner. 1998. Bacterial DNA and immunostimulatory CpG oligonucle-
otides trigger maturation and activation of murine dendritic cells. Eur. J. Immu-
nol. 28:2045.
10. Chu, R. S., O. S. Targoni, A. M. Krieg, P. V. Lehmann, and C. V. Harding. 1997.
CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1)
immunity. J. Exp. Med. 186:1623.
11. Whelan, M., M. M. Harnett, K. M. Houston, V. Patel, W. Harnett, and
K. P. Rigley. 2000. A filarial nematode-secreted product signals dendritic cells to
acquire a phenotype that drives development of Th2 cells. J. Immunol. 164:6453.
12. Langenkamp, A., M. Messi, A. Lanzavecchia, and F. Sallusto. 2000. Kinetics of
dendritic cell activation: impact on priming of Th1, Th2 and nonpolarized T cells.
Nat. Immunol. 1:311.
13. De Becker, G., V. Moulin, F. Tielemans, F. De Mattia, J. Urbain, O. Leo, and
M. Moser. 1998. Regulation of T helper cell differentiation in vivo by soluble and
membrane proteins provided by antigen-presenting cells. Eur. J. Immunol.
28:3161.
14. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu,
J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996.
IL-12-deficient mice are defective in IFN  production and type 1 cytokine re-
sponses. Immunity 4:471.
15. Jankovic, D., Z. Liu, and W. C. Gause. 2001. Th1- and Th2-cell commitment
during infectious disease: asymmetry in divergent pathways. Trends Immunol.
22:450.
16. Jankovic, D., M. C. Kullberg, S. Hieny, P. Caspar, C. M. Collazo, and A. Sher.
2002. In the absence of IL-12, CD4 T cell responses to intracellular pathogens
fail to default to a Th2 pattern and are host protective in an IL-10/ setting.
Immunity 16:429.
17. Rempel, J. D., I. P. Lewkowich, and K. T. HayGlass. 2000. Endogenous IL-12
synthesis is not required to prevent hyperexpression of type 2 cytokine and an-
tibody responses. Eur. J. Immunol. 30:347.
18. Holt, P. G., C. Macaubas, P. A. Stumbles, and P. D. Sly. 1999.The role of allergy
in the development of asthma. Nature 402:B12.
19. Umetsu, D. T., J. J. McIntire, O. Akbari, C. Macaubas, and R. H. DeKruyff. 2002.
Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715.
20. Riedler, J., C. Braun-Fahrlander, W. Eder, M. Schreuer, M. Waser, S. Maisch,
D. Carr, R. Schierl, D. Nowak, and E. von Mutius. 2001. Exposure to farming in
early life and development of asthma and allergy: a cross-sectional survey. Lan-
cet 358:1129.
21. Tulic, M. K., J. L. Wale, P. G. Holt, and P. D. Sly. 2000. Modification of the
inflammatory response to allergen challenge after exposure to bacterial lipopoly-
saccharide. Am. J. Respir. Cell Mol. Biol. 22:604.
22. Gerhold, K., K. Blumchen, A. Bock, C. Seib, P. Stock, T. Kallinich, M. Lohning,
U. Wahn, and E. Hamelmann. 2002. Endotoxins prevent murine IgE production,
Th2 immune responses, and development of airway eosinophilia but not airway
hyperreactivity. J. Allergy Clin. Immunol. 110:110.
23. Lambrecht, B. N., B. Salomon, D. Klatzmann, and R. A. Pauwels. 1998. Den-
dritic cells are required for the development of chronic eosinophilic airway in-
flammation in response to inhaled antigen in sensitized mice. J. Immunol.
160:4090.
24. Murphy, K. M., A. B. Heimberger, and D. Y. Loh. 1990. Induction by antigen of
intrathymic apoptosis of CD4CD8TCRlo thymocytes in vivo. Science
250:1720.
25. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and
G. Schuler. 1999. An advanced culture method for generating large quantities of
highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods
223:77.
26. Lambrecht, B. N., R. A. Pauwels, and B. Fazekas De St. Groth. 2000. Induction
of rapid T cell activation, division, and recirculation by intratracheal injection of
dendritic cells in a TCR transgenic model. J. Immunol. 164:2937.
27. Ho, W., and A. Furst. 1973. Intratracheal instillation method for mouse lungs.
Oncology 27:385.
3653The Journal of Immunology
28. van Rijt, L. S., J. B. Prins, P. J. Leenen, K. Thielemans, V. C. de Vries,
H. C. Hoogsteden, and B. N. Lambrecht. 2002. Allergen-induced accumulation of
airway dendritic cells is supported by an increase in CD31hiLy-6Cneg bone mar-
row precursors in a mouse model of asthma. Blood 100:3663.
29. O’Garra, A. 1998. Cytokines induce the development of functionally heteroge-
neous T helper cell subsets. Immunity 8:275.
30. Seder, R. A., R. Gazzinelli, A. Sher, and W. E. Paul. 1993. Interleukin 12 acts
directly on CD4 T cells to enhance priming for interferon  production and
diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA
90:10188.
31. Kalinski, P., J. H. Schuitemaker, C. M. Hilkens, E. A. Wierenga, and
M. L. Kapsenberg. 1999. Final maturation of dendritic cells is associated with
impaired responsiveness to IFN- and to bacterial IL-12 inducers: decreased
ability of mature dendritic cells to produce IL-12 during the interaction with Th
cells. J. Immunol. 162:3231.
32. Schulz, O., D. A. Edwards, M. Schito, J. Aliberti, S. Manickasingham, A. Sher,
and C. Reis e Sousa. 2000. CD40 triggering of heterodimeric IL-12 p70 produc-
tion by dendritic cells in vivo requires a microbial priming signal. Immunity
13:453.
33. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins
linking innate and acquired immunity. Nat. Immunol. 2:675.
34. Edwards, A. D., S. P. Manickasingham, R. Sporri, S. S. Diebold, O. Schulz,
A. Sher, T. Kaisho, S. Akira, and E. S. C. Reis. 2002. Microbial recognition via
Toll-like receptor-dependent and -independent pathways determines the cytokine
response of murine dendritic cell subsets to CD40 triggering. J. Immunol.
169:3652.
35. Tao, X., S. Constant, P. Jorritsma, and K. Bottomly. 1997. Strength of TCR signal
determines the costimulatory requirements for Th1 and Th2 CD4 T cell differ-
entiation. J. Immunol. 159:5956.
36. Pflanz, S., J. C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L. Hibbert,
T. Churakova, M. Travis, E. Vaisberg, et al. 2002. IL-27, a heterodimeric cyto-
kine composed of EBI3 and p28 protein, induces proliferation of naive CD4 T
cells. Immunity 16:779.
37. Fukao, T., M. Tanabe, Y. Terauchi, T. Ota, S. Matsuda, T. Asano, T. Kadowaki,
T. Takeuchi, and S. Koyasu. 2002. PI3K-mediated negative feedback regulation
of IL-12 production in DCs. Nat. Immunol. 3:875.
38. Shreedhar, V., A. M. Moodycliffe, S. E. Ullrich, C. Bucana, M. L. Kripke, and
L. Flores-Romo. 1999. Dendritic cells require T cells for functional maturation in
vivo. Immunity 11:625.
39. Rizzitelli, A., R. Berthier, V. Collin, S. M. Candeias, and P. N. Marche. 2002. T
lymphocytes potentiate murine dendritic cells to produce IL-12. J. Immunol.
169:4237.
40. Josien, R., H. L. Li, E. Ingulli, S. Sarma, B. R. Wong, M. Vologodskaia,
R. M. Steinman, and Y. Choi. 2000. TRANCE, a tumor necrosis factor family
member, enhances the longevity and adjuvant properties of dendritic cells in vivo.
J. Exp. Med. 191:495.
41. Sung, S., C. E. Rose, and S. M. Fu. 2001. Intratracheal priming with ovalbumin-
and ovalbumin 323–339 peptide-pulsed dendritic cells induces airway hyperre-
sponsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation. J. Im-
munol. 166:1261.
42. Gavett, S. H., D. J. O’Hearn, X. Li, S. K. Huang, F. D. Finkelman, and
M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperre-
sponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med.
182:1527.
43. Iwamoto, I., K. Kumano, M. Kasai, K. Kurasawa, and A. Nakao. 1996. Inter-
leukin-12 prevents antigen-induced eosinophil recruitment into mouse airways.
Am. J. Respir. Crit. Care Med. 154:1257.
44. Keane-Myers, A., M. Wysocka, G. Trinchieri, and M. Wills-Karp. 1998. Resis-
tance to antigen-induced airway hyperresponsiveness requires endogenous pro-
duction of IL-12. J. Immunol. 161:919.
45. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns
of lymphokine secretion lead to different functional properties. Annu. Rev. Im-
munol. 7:145.
46. Freudenberg, M. A., T. Merlin, C. Kalis, Y. Chvatchko, H. Stubig, and
C. Galanos. 2002. Cutting edge: a murine, IL-12-independent pathway of IFN-
induction by Gram-negative bacteria based on STAT4 activation by type I IFN
and IL-18 signaling. J. Immunol. 169:1665.
47. Mullen, A. C., F. A. High, A. S. Hutchins, H. W. Lee, A. V. Villarino,
D. M. Livingston, A. L. Kung, N. Cereb, T. P. Yao, S. Y. Yang, and S. L. Reiner.
2001. Role of T-bet in commitment of Th1 cells before IL-12-dependent selec-
tion. Science 292:1907.
48. Chen, Q., N. Ghilardi, H. Wang, T. Baker, M. H. Xie, A. Gurney, I. S. Grewal,
and F. J. de Sauvage. 2000. Development of Th1-type immune responses requires
the type I cytokine receptor TCCR. Nature 407:916.
49. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega,
N. Yu, J. Wang, K. Singh, et al. 2000. Novel p19 protein engages IL-12p40 to
form a cytokine, IL-23, with biological activities similar as well as distinct from
IL-12. Immunity 13:715.
50. Kalinski, P., C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. T-cell
priming by type-1 and type-2 polarized dendritic cells: the concept of a third
signal. Immunol. Today 20:561.
51. van der Pouw Kraan, T. C., L. C. Boeije, E. R. de Groot, S. O. Stapel, A. Snijders,
M. L. Kapsenberg, J. S. van der Zee, and L. A. Aarden. 1997. Reduced produc-
tion of IL-12 and IL-12-dependent IFN- release in patients with allergic asthma.
J. Immunol. 158:5560.
52. Reider, N., D. Reider, S. Ebner, S. Holzmann, M. Herold, P. Fritsch, and
N. Romani. 2002. Dendritic cells contribute to the development of atopy by an
insufficiency in IL-12 production. J. Allergy Clin. Immunol. 109:89.
53. Morahan, G., D. Huang, M. Wu, B. J. Holt, G. P. White, G. E. Kendall, P. D. Sly,
and P. G. Holt. 2002. Association of IL12B promoter polymorphism with severity
of atopic and non-atopic asthma in children. Lancet 360:455.
54. Reed, C. E., and D. K. Milton. 2001. Endotoxin-stimulated innate immunity: a
contributing factor for asthma. J. Allergy Clin. Immunol. 108:157.
55. Michel, O., J. Kips, J. Duchateau, F. Vertongen, L. Robert, H. Collet, R. Pauwels,
and R. Sergysels. 1996. Severity of asthma is related to endotoxin in house dust.
Am. J. Respir. Crit. Care Med. 154:1641.
56. Vannier, E., J. Lefort, A. Lellouch-Tubiana, B. Terlain, and B. B. Vargaftig.
1991. Lipopolysaccharide from Escherichia coli reduces antigen-induced bron-
choconstriction in actively sensitized guinea pigs. J. Clin. Invest. 87:1936.
57. Wan, G. H., C. S. Li, and R. H. Lin. 2000. Airborne endotoxin exposure and the
development of airway antigen-specific allergic responses. Clin. Exp. Allergy
30:426.
58. Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and
K. Bottomly. 2002. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent
T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:1645.
59. Kline, J. N., A. M. Krieg, T. J. Waldschmidt, Z. K. Ballas, V. Jain, and
T. R. Businga. 1999. CpG oligodeoxynucleotides do not require Th1 cytokines to
prevent eosinophilic airway inflammation in a murine model of asthma.
J. Allergy Clin. Immunol. 104:1258.
60. Braun-Fahrlander, C., J. Riedler, U. Herz, W. Eder, M. Waser, L. Grize,
S. Maisch, D. Carr, F. Gerlach, A. Bufe, et al. 2002. Environmental exposure to
endotoxin and its relation to asthma in school-age children. N. Engl. J. Med.
347:869.
61. Akbari, O., G. J. Freeman, E. H. Meyer, E. A. Greenfield, T. T. Chang,
A. H. Sharpe, G. Berry, R. H. DeKruyff, and D. T. Umetsu. 2002. Antigen-
specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and in-
hibit allergen-induced airway hyperreactivity. Nat. Med. 8:1024.
62. Zuany-Amorim, C., E. Sawicka, C. Manlius, A. Le Moine, L. R. Brunet,
D. M. Kemeny, G. Bowen, G. Rook, and C. Walker. 2002. Suppression of airway
eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regula-
tory T-cells. Nat. Med. 8:625.
3654 IL-12-INDEPENDENT SUPPRESSION OF AIRWAY Th2 RESPONSES BY LPS
